ResearcherFirst Affiliated Hospital of Nanchang UniversityNo recent work listed

Weidan Fang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5035890602. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2023: 1 paper

Papers 1

Upregulated GPRC5A disrupting the Hippo pathway promotes the proliferation and migration of pancreatic cancer cells via the cAMP-CREB axis. Co-author DOI 10.1007/s12672-023-00626-1 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xin Yu · 1 shared paper, 2023 · strength 0.22
- Paper Upregulated GPRC5A disrupting the Hippo pathway promotes the proliferation and migration of pancreatic cancer cells via… DOI 10.1007/s12672-023-00626-1 ↗
Mei Ma · 1 shared paper, 2023 · strength 0.22
- Paper Upregulated GPRC5A disrupting the Hippo pathway promotes the proliferation and migration of pancreatic cancer cells via… DOI 10.1007/s12672-023-00626-1 ↗
Jianping Xiong · 1 shared paper, 2023 · strength 0.22
- Paper Upregulated GPRC5A disrupting the Hippo pathway promotes the proliferation and migration of pancreatic cancer cells via… DOI 10.1007/s12672-023-00626-1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.